Sensus Healthcare, Inc.

SRTS

Sensus Healthcare, Inc.

SRTS

Insider Sentiment (TTM):

Last Purchase:2026-05-12Last Sale:2024-05-20Shares Purchased (TTM):40,000Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:3,839,077Shares Outstanding:16,462,653Institutional Ownership Pct.:23.32%

Earnings Market Reaction:

Filing Date:2026-08-14Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	15	18	22	24	22	19	22	23	19	15	23	20
Accounts Receivable Net Current	2	4	6	9	13	18	20	17	18	20	11	7
Inventory Net	18	17	15	13	12	10	10	12	13	15	12	13
Prepaid Expense Current	1	2	2	1	3	6	3	2	3	4	3	4
Other Assets Current	2	2	2	2	2	2	2	2	1	1	1	1
Assets Current	38	43	46	50	52	54	57	55	54	54	50	46
Property Plant And Equipment Net	3	2	2	3	3	3	2	2	1	1	0	0
Intangible Assets Net Excluding Goodwill	-	-	-	-	-	-	-	-	-	-	-	0
Deposits Assets Noncurrent	-	-	-	-	-	-	-	-	-	-	-	0
Deferred Income Tax Assets Net	-	6	4	4	3	2	2	2	2	1	2	3
Operating Lease Right Of Use Asset	0	0	0	1	1	1	1	1	1	1	1	1
Other Assets Noncurrent	1	1	1	1	1	1	1	1	1	1	1	0
Assets	41	52	53	58	59	60	62	60	58	57	54	51
Liabilities And Stockhold…
Liabilities Current
Accounts Payable And Accrued Liabilities Current	3	5	3	6	5	6	5	4	3	4	3	4
Product Warranty Accrual Classified Current	0	0	0	0	0	0	0	0	1	1	1	0
Operating Lease Liability Current	0	0	0	0	0	0	0	0	0	0	0	0
Taxes Payable Current	-	-	-	-	-	-	-	-	-	0	0	-
Deferred Revenue Current	1	1	1	1	1	1	1	1	1	1	1	1
Liabilities Current	4	6	5	7	6	7	6	5	5	5	4	5
Operating Lease Liability Noncurrent	0	0	0	0	0	0	0	0	1	1	1	1
Contract With Customer Liability Noncurrent	-	-	-	-	-	-	-	0	0	-	-	-
Deferred Revenue Noncurrent	-	0	0	0	0	0	0	-	-	0	0	0
Liabilities	4	6	5	7	7	7	6	6	5	6	5	6
Stockholders Equity
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	46	46	46	46	46	46	46	46	46	45	45	45
Treasury Stock Value	-4	-4	-4	-4	-4	-4	-4	-4	-4	-4	-4	-4
Retained Earnings Accumulated Deficit	-6	3	6	9	10	11	13	12	11	9	7	3
Stockholders Equity	37	46	48	51	52	53	56	54	53	51	49	45
Liabilities And Stockholders Equity	41	52	53	58	59	60	62	60	58	57	54	51
Preferred Stock Shares Authorized	5	5	5	5	5	5	5	5	5	5	5	5
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	-	-	-	0	-
Preferred Stock Shares Issued	0	0	0	0	0	0	0	-	-	-	0	-
Common Stock Par Or Stated Value Per Share	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Common Stock Shares Authorized	50	50	50	50	50	50	50	50	50	50	50	50
Common Stock Shares Issued	17	17	17	17	17	17	17	17	17	17	17	17
Shares Outstanding	16	16	16	16	16	16	16	16	16	16	16	16
Treasury Stock Common Shares	1	1	1	1	1	1	1	1	1	1	1	1

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-21.74%	-11.01%	-16.23%	-	-	-	-	-	-	-	-	-
2025	5.58%	0.00%	19.74%	-1.22%	4.89%	-2.45%	-15.22%	-10.87%	11.52%	-11.11%	-10.66%	-27.66%
2024	2.46%	0.76%	18.53%	-14.15%	-2.18%	2.18%	21.12%	-0.55%	12.96%	1.71%	1.07%	0.00%
2023	-	-	-	-	-	-	19.68%	40.64%	68.98%	-1.99%	3.69%	53.98%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	8.71	7.27	9.72	7.38	8.14	8.06	9.64	10.52	11.63	9.85	11.76	8.77
Quick Ratio	4.30	4.03	6.31	5.27	5.79	5.74	7.36	7.89	8.20	6.49	8.23	5.49
Working Capital	33.35M	36.73M	41.17M	43.40M	45.81M	47.47M	50.85M	49.60M	49.79M	48.44M	45.32M	40.63M
Leverage & Debt
Debt to Equity	0.12	0.13	0.10	0.14	0.13	0.14	0.11	0.11	0.10	0.12	0.10	0.13
Interest Coverage TTM	-23.76	-19.26	-15.09	-4.60	-1.05	1.93	5.97	17.01	20.22	25.44	-1.57	-2.87
Debt Ratio	0.11	0.12	0.09	0.12	0.12	0.12	0.10	0.10	0.09	0.11	0.09	0.12
Efficiency & Turnover
Asset Turnover TTM	0.35	0.40	0.48	0.60	0.64	0.67	0.72	0.75	0.66	0.57	0.44	0.47
Days Sales Outstanding TTM	149.09	174.92	171.14	134.77	150.20	173.97	132.60	105.35	137.72	186.56	208.96	104.47
Receivables Turnover TTM	2.45	2.09	2.13	2.71	2.43	2.10	2.75	3.46	2.65	1.96	1.75	3.49
Per Share Metrics
Diluted EPS TTM	-0.94	-0.47	-0.47	-0.18	-0.05	0.11	0.41	0.57	0.41	0.29	0.03	-0.06
Free Cash Flow Per Share TTM	-0.42	-0.04	0.02	0.10	0.18	0.25	-0.10	0.13	-0.07	-0.28	-0.15	-0.93
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	36.39%	37.74%	43.18%	47.95%	52.19%	56.02%	58.44%	60.90%	60.23%	60.34%	57.61%	58.45%
Operating Profit Margin TTM	-75.72%	-53.34%	-37.50%	-15.25%	-3.64%	6.48%	19.35%	28.91%	23.52%	17.20%	-1.57%	-7.18%
Net Profit Margin TTM	-88.45%	-34.50%	-28.09%	-8.44%	-2.26%	4.56%	15.90%	22.54%	18.27%	14.70%	1.99%	-3.59%
Growth Metrics
Net Revenue Growth (1Y)	-53.39%	-42.94%	-34.26%	-13.79%	3.29%	24.75%	71.31%	65.61%	21.00%	-15.83%	-45.20%	-43.89%
Net Income Growth (1Y)	1,726.06%	-531.59%	-216.13%	-132.28%	-112.76%	-61.29%	1,270.52%	-1,139.17%	178.73%	-26.00%	-98.00%	-103.35%
EPS Growth (1Y)	1,710.31%	-528.43%	-216.02%	-132.29%	-112.74%	-61.40%	1,266.05%	-1,135.94%	177.90%	-26.23%	-97.97%	-103.39%
Valuation Metrics
P/E TTM	-3.21	-8.43	-8.42	-17.05	-91.22	42.92	16.98	10.17	13.07	13.31	79.12	-50.30
P/B TTM	1.35	1.44	1.35	1.00	1.49	1.46	2.02	1.75	1.64	1.21	0.79	1.01
P/S TTM	2.84	2.91	2.36	1.44	2.06	1.96	2.70	2.29	2.39	1.96	1.57	1.81
Market Cap	49.72M	65.52M	64.98M	51.24M	77.36M	77.30M	112.88M	94.66M	86.87M	61.92M	38.37M	45.07M
Enterprise Value	34.53M	47.19M	42.90M	26.79M	55.19M	58.23M	90.83M	72.10M	67.90M	47.19M	15.22M	24.58M
Calculated Values
Free Cash Flow TTM	-6.97M	-740.00K	332.00K	1.57M	2.90M	4.04M	-1.70M	2.09M	-1.09M	-4.61M	-2.37M	-15.17M
Net Debt	-15.19M	-18.33M	-22.08M	-24.45M	-22.16M	-19.07M	-22.06M	-22.56M	-18.97M	-14.73M	-23.15M	-20.49M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-05-12Purchase

Owner: Sachetta, Eric

Title: -

Shares: 1,500

Price/Share: $3.34

Value: $5,010.00

Shares Owned: 143,613

Relationship: Director

Ownership: Direct

2026-02-24Purchase

Owner: Sachetta, Eric

Title: -

Shares: 2,000

Price/Share: $3.81

Value: $7,620.00

Shares Owned: 142,113

Relationship: Director

Ownership: Direct

2025-11-21Purchase

Owner: Sachetta, Eric

Title: -

Shares: 7,000

Price/Share: $3.93

Value: $27,510.00

Shares Owned: 140,113

Relationship: Director

Ownership: Direct

2025-11-18Purchase

Owner: Sardano, Joseph C

Title: CHIEF EXECUTIVE OFFICER

Shares: 25,000

Price/Share: $4.03

Value: $100,750.00

Shares Owned: 1,200,293

Relationship: Director,Officer

Ownership: Direct

2025-11-18Purchase

Owner: Sardano, Michael

Title: PRESIDENT AND GENERAL COUNSEL

Shares: 1,000

Price/Share: $3.80

Value: $3,800.00

Shares Owned: 118,839

Relationship: Director,Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-05-12	Sachetta, Eric	Director	-	Direct	Purchase	1,500	3.34	$5,010.00	143,613	4
2026-02-24	Sachetta, Eric	Director	-	Direct	Purchase	2,000	3.81	$7,620.00	142,113	4
2025-11-21	Sachetta, Eric	Director	-	Direct	Purchase	7,000	3.93	$27,510.00	140,113	4
2025-11-18	Sardano, Joseph C	Director,Officer	CHIEF EXECUTIVE OFFICER	Direct	Purchase	25,000	4.03	$100,750.00	1,200,293	4
2025-11-18	Sardano, Michael	Director,Officer	PRESIDENT AND GENERAL COUNSEL	Direct	Purchase	1,000	3.80	$3,800.00	118,839	4
2025-11-13	Sachetta, Eric	Director	-	Direct	Purchase	2,500	4.50	$11,250.00	133,113	4
2025-11-11	Sardano, Michael	Director,Officer	PRESIDENT AND GENERAL COUNSEL	Direct	Purchase	1,000	4.26	$4,260.00	117,839	4/A
2025-08-13	Sardano, Michael	Director,Officer	PRESIDENT AND GENERAL COUNSEL	Direct	Purchase	1,000	3.37	$3,370.00	116,839	4
2025-02-10	Rampolla, Javier	Officer	CHIEF FINANCIAL OFFICER	Direct	Purchase	501	5.95	$2,980.95	40,745	4
2025-02-10	Sardano, Michael	Director,Officer	PRESIDENT AND GENERAL COUNSEL	Direct	Purchase	1,000	5.95	$5,950.00	115,839	4
2024-05-20	Heinrich, John	Director	-	Direct	Sale	15,227	6.24	$95,016.48	59,940	4
2023-09-14	Sardano, Joseph C	Director,Officer	CHIEF EXECUTIVE OFFICER	Direct	Purchase	10,000	2.88	$28,800.00	1,175,293	4
2023-08-28	Sardano, Michael	Officer	PRESIDENT AND GENERAL COUNSEL	Direct	Purchase	1,000	2.99	$2,990.00	58,774	4
2023-08-08	Sardano, Joseph C	Director,Officer	CHIEF EXECUTIVE OFFICER	Direct	Purchase	10,000	3.86	$38,600.00	1,165,293	4
2023-08-08	Sardano, Michael	Officer	PRESIDENT AND GENERAL COUNSEL	Direct	Purchase	1,000	3.78	$3,780.00	57,774	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

23.32%

Inst. Shares: 3,839,077

Shares Outstanding: 16,462,653

2025-12-31

23.90%

Inst. Shares: 3,902,456

Shares Outstanding: 16,326,937

2025-09-30

24.06%

Inst. Shares: 3,927,190

Shares Outstanding: 16,320,036

2025-06-30

26.46%

Inst. Shares: 4,317,840

Shares Outstanding: 16,320,036

2025-03-31

21.09%

Inst. Shares: 3,446,029

Shares Outstanding: 16,341,867

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	3,839,077	16,462,653	23.32%
2025-12-31	3,902,456	16,326,937	23.90%
2025-09-30	3,927,190	16,320,036	24.06%
2025-06-30	4,317,840	16,320,036	26.46%
2025-03-31	3,446,029	16,341,867	21.09%
2024-12-31	4,428,346	16,312,351	27.15%
2024-09-30	3,541,421	16,321,131	21.70%
2024-06-30	3,092,931	16,298,459	18.98%
2024-03-31	2,068,624	16,294,970	12.69%
2023-12-31	2,174,260	16,259,254	13.37%
2023-09-30	2,089,853	16,270,403	12.84%
2023-06-30	2,302,485	16,249,766	14.17%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Sensus Healthcare, Inc. (SRTS) — SEC Financial Statements & Analysis

Sensus Healthcare, Inc. (SRTS) is a surgical & medical instruments & apparatus company, incorporated in DE. Sensus Healthcare, Inc. trades on Nasdaq as: SRTS. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Sensus Healthcare, Inc. reported a -53.39% year-over-year revenue growth, a Gross Profit Margin of 36.39% (TTM), a Debt-to-Equity ratio of 0.12x, a Price-to-Sales (P/S) ratio of 2.84x (TTM), a Price-to-Book (P/B) ratio of 1.35x (TTM), at a market cap of $49.72M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: -53.39%
Gross Profit Margin TTM: 36.39%
Debt To Equity: 0.12x
P/S TTM: 2.84x
P/B TTM: 1.35x
Market Cap: $49.72M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Sensus Healthcare, Inc. in?

Sensus Healthcare, Inc. (SRTS) operates in the Surgical & Medical Instruments & Apparatus industry.

What is SRTS's market cap?

Sensus Healthcare, Inc. (SRTS) has a market capitalization of $49.72M as of 2026-06-30.

What exchange does SRTS trade on?

Sensus Healthcare, Inc. (SRTS) trades on the Nasdaq.

Where is Sensus Healthcare, Inc. incorporated?

Sensus Healthcare, Inc. is incorporated in DE.